Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages

J Biol Chem. 2002 Oct 11;277(41):38104-10. doi: 10.1074/jbc.M206167200. Epub 2002 Aug 12.

Abstract

The RON receptor tyrosine kinase is activated by macrophage-stimulating protein, which regulates macrophage migration, phagocytosis, and nitric oxide production. We report here the inhibitory effect of RON on lipopolysaccharide (LPS)-induced cyclooxygenase (Cox)-2 expression in mouse macrophages. In RON-expressing macrophages treated with macrophage stimulating protein, LPS-induced prostaglandin E(2) (PGE(2)) production was significantly reduced. The inhibition was accompanied by reduction of Cox-2 protein and mRNA expression. Transcriptional studies indicated that RON activation inhibits LPS-induced luciferase activity driven by the Cox-2 gene promoter. To determine whether RON activation affects LPS-induced NF-kappa B pathway, which is important for Cox-2 expression. Western blot analyses were performed showing that RON activation inhibits LPS-induced I kappa B alpha degradation. The decreased I kappa B alpha degradation was due to reduced I kappa B alpha phosphorylation at Ser-32 as determined by I kappa B alpha (Ser-32) phosphor-antibody. Moreover, we found that LPS-induced IKK beta activity, an enzyme responsible for phosphorylation of I kappa B alpha, was inhibited upon RON activation. Interestingly, these inhibitory effects were not regulated by RON-mediated phosphatidylinositol-3 kinase. These results suggest that RON activation inhibits LPS-induced macrophage Cox-2 expression. The inhibitory effect is mediated by impairing LPS-activated cascade enzymes that activate NF-kappa B. The inhibition of Cox-2 expression might represent a novel mechanism for the inhibitory functions of RON in vivo against LPS-induced inflammation and septic shock.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Androstadienes / pharmacology
  • Animals
  • Cells, Cultured
  • Culture Media, Serum-Free
  • Cyclooxygenase 2
  • DNA-Binding Proteins / metabolism
  • Enzyme Activation*
  • Hepatocyte Growth Factor / metabolism*
  • I-kappa B Kinase
  • I-kappa B Proteins*
  • Interferon-gamma / pharmacology
  • Isoenzymes / genetics
  • Isoenzymes / metabolism*
  • Lipopolysaccharides / pharmacology
  • Macrophages / drug effects
  • Macrophages / enzymology*
  • Mice
  • NF-KappaB Inhibitor alpha
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Promoter Regions, Genetic
  • Prostaglandin-Endoperoxide Synthases / genetics
  • Prostaglandin-Endoperoxide Synthases / metabolism*
  • Protein Serine-Threonine Kinases / metabolism
  • Proto-Oncogene Proteins / metabolism*
  • Receptor Protein-Tyrosine Kinases / genetics
  • Receptor Protein-Tyrosine Kinases / metabolism*
  • Receptors, Cell Surface / genetics
  • Receptors, Cell Surface / metabolism*
  • Tetradecanoylphorbol Acetate / pharmacology
  • Wortmannin

Substances

  • Androstadienes
  • Culture Media, Serum-Free
  • DNA-Binding Proteins
  • I-kappa B Proteins
  • Isoenzymes
  • Lipopolysaccharides
  • Nfkbia protein, mouse
  • Phosphoinositide-3 Kinase Inhibitors
  • Proto-Oncogene Proteins
  • Receptors, Cell Surface
  • macrophage stimulating protein
  • NF-KappaB Inhibitor alpha
  • Hepatocyte Growth Factor
  • Interferon-gamma
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • RON protein
  • Receptor Protein-Tyrosine Kinases
  • Protein Serine-Threonine Kinases
  • Chuk protein, mouse
  • I-kappa B Kinase
  • Ikbkb protein, mouse
  • Ikbke protein, mouse
  • Tetradecanoylphorbol Acetate
  • Wortmannin